Viracta Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Viracta Therapeutics Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Viracta Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Viracta Therapeutics Inc.

Back to companies

Viracta Therapeutics Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Viracta Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP3466929B1 Grant Als pdk1-inhibitoren nützliche heterocyclische verbindungen A61K31/437; A61K31/4427; A61K31/4439; A61K31/444; A61K31/452; A61K31/4725; A61K31/495; A61K31/496; A61K31/497; A61K31/498; A61K31/4985; A61K31/505; A61K31/517; A61K31/519; A61K31/53; A61K31/5377; A61K31/5383; A61P35/00; A61P35/02; A61P35/04; C07D213/82; C07D213/85; C07D241/26; C07D241/28; C07D401/12; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07D407/14; C07D409/04; C07D409/14; C07D413/14; C07D417/14; C07D471/04; C07D473/34; C07D487/04; C07D491/052; C07D498/04; C07D519/00 September 06, 2023
IL302896A Application Heterocyclic compounds useful as pdk1 inhibitors A61K31/437; A61K31/4427; A61K31/4439; A61K31/444; A61K31/452; A61K31/4725; A61K31/495; A61K31/496; A61K31/497; A61K31/498; A61K31/4985; A61K31/505; A61K31/517; A61K31/519; A61K31/53; A61K31/5377; A61K31/5383; A61P35/00; A61P35/02; A61P35/04; C07D213/82; C07D213/85; C07D241/26; C07D241/28; C07D401/12; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07D407/14; C07D409/04; C07D409/14; C07D413/14; C07D417/14; C07D471/04; C07D473/34; C07D487/04; C07D491/052; C07D498/04; C07D519/00 July 01, 2023
US20230174511A1 Application Pyrimidinyl tyrosine kinase inhibitors A61P1/16; A61P17/00; A61P19/02; A61P19/10; A61P29/00; A61P35/00; A61P35/02; A61P37/00; A61P37/02; A61P37/06; A61P37/08; A61P43/00; A61P7/06; A61P9/06; C07D401/14 June 08, 2023
WO2023081709A1 Application Vecabrutinib for the treatment of graft-versus-host disease A61K31/00; A61K31/505; A61P37/06 May 11, 2023
WO2023081715A1 Application Combination of car t-cell therapy with btk inhibitors and methods of use thereof A61K2039/5156; A61K2039/5158; A61K2300/00; A61K31/506; A61K39/001112; A61P35/00 May 11, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer